The FDA is considering allowing compounding pharmacies to make unproven peptides—sparking fears around efficacy and safety.
From Looksmaxxing to FDA Approval? The U.S. Considers Greenlighting Mystery Peptides
You Might Also Like
Condom Maker’s 30 Percent Price Hike Highlights Iran War’s Unexpected Impacts
Products are set to inflate, or be late.
Deloitte and Zoom trim parental leave and other benefits
Starting next year, Deloitte and Zoom are cutting back on some of the most treasured employee benefits, Business Insider reports.…
Tim Cook’s Biggest Win Wasn’t the iPhone—It Was This $100 Billion Move
Cook laid the groundwork for Apple’s transition into a service-based powerhouse and grew the company to be worth about $4…
AI Is Making Founders Obsolete—Unless They Master These 5 Human Skills
Here’s how to win in business when AI is smarter than you.
